Screener
Bio-Techne TECH EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Bio-Techne’s reported figures.
Plus components not separately reported this period.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
FAQ
- What is Bio-Techne's EBIT?
- Bio-Techne (TECH) reported EBIT of $75.5M in Q1 2026.
- How has Bio-Techne's EBIT changed year-over-year?
- Bio-Techne's EBIT increased by 95.0% year-over-year, from $38.71M to $75.5M.
- What is the long-term trend for Bio-Techne's EBIT?
- Over 2 years (2022 to 2024), Bio-Techne's EBIT has grown at a -16.5% compound annual growth rate (CAGR), from $296.59M to $206.69M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Bio-Techne's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude